Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jan Paul, de Boer"'
Autor:
Floortje Mols, Dounya Schoormans, Romana Netea-Maier, Olga Husson, Sandra Beijer, Katrijn Van Deun, Wouter Zandee, Marleen Kars, Pleun C. M. Wouters van Poppel, Suat Simsek, Patrick van Battum, Jérôme M. H. Kisters, Jan Paul de Boer, Elske Massolt, Rachel van Leeuwaarde, Wilma Oranje, Sean Roerink, Mechteld Vermeulen, Lonneke van de Poll-Franse
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-9 (2023)
Abstract Background Thyroid cancer (TC) patients are understudied but appear to be at risk for poor physical and psychosocial outcomes. Knowledge of the course and determinants of these deteriorated outcomes is lacking. Furthermore, little is known a
Externí odkaz:
https://doaj.org/article/999313e7c3b8487d9e71c189727430cd
Autor:
Marceline W. Piek, Jan Paul de Boer, Frederieke van Duijnhoven, Jacqueline E. van der Wal, Menno Vriens, Rachel S. van Leeuwaarde, Iris M. C. van der Ploeg
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the occurrence of both is higher than expected by cha
Externí odkaz:
https://doaj.org/article/3e1503471f81466aad7722b3e321f657
Autor:
Anouk W. M. A. Schaeffers, Lot A. Devriese, Carla H. van Gils, Jan Willem Dankbaar, Jens Voortman, Jan Paul de Boer, Marije Slingerland, Mathijs P. Hendriks, Ernst J. Smid, Geert W. J. Frederix, Remco de Bree
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/384294a837e14ac9ba26c18410221c79
Autor:
Joris L. Vos, Joris B. W. Elbers, Oscar Krijgsman, Joleen J. H. Traets, Xiaohang Qiao, Anne M. van der Leun, Yoni Lubeck, Iris M. Seignette, Laura A. Smit, Stefan M. Willems, Michiel W. M. van den Brekel, Richard Dirven, M. Baris Karakullukcu, Luc Karssemakers, W. Martin C. Klop, Peter J. F. M. Lohuis, Willem H. Schreuder, Ludi E. Smeele, Lilly-Ann van der Velden, I. Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V. Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B. A. G. Haanen, Charlotte L. Zuur
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Immune checkpoint blockade has become standard care for patients with recurrent metastatic head and neck squamous cell carcinoma (HNSCC). Here the authors present the results of a non-randomized phase Ib/IIa trial, reporting safety and efficacy of ne
Externí odkaz:
https://doaj.org/article/761c20eac4bf4e0f8dc9495fdeadff61
Autor:
Bianca Cioni, Anniek Zaalberg, Judy R. van Beijnum, Monique H. M. Melis, Johan van Burgsteden, Mauro J. Muraro, Erik Hooijberg, Dennis Peters, Ingrid Hofland, Yoni Lubeck, Jeroen de Jong, Joyce Sanders, Judith Vivié, Henk G. van der Poel, Jan Paul de Boer, Arjan W. Griffioen, Wilbert Zwart, Andries M. Bergman
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Anti-androgen therapy inhibits prostate cancer (PC) progression, and is thought to act directly on cancer cells. Here the authors show that androgen receptor is expressed on normal and PC-associated macrophages, and its stimulation alters macrophage
Externí odkaz:
https://doaj.org/article/3be95a4024404f56acd7fe8a4155f96c
Autor:
Cathelijn E.M. Aarts, Ida H. Hiemstra, Eelke P. Béguin, Arjan J. Hoogendijk, Souhailla Bouchmal, Michel van Houdt, Anton T.J. Tool, Erik Mul, Machiel H. Jansen, Hans Janssen, Floris P.J. van Alphen, Jan-Paul de Boer, Charlotte L. Zuur, Alexander B. Meijer, Timo K. van den Berg, Taco W. Kuijpers
Publikováno v:
Blood Advances, Vol 3, Iss 22, Pp 3562-3574 (2019)
Abstract: Myeloid-derived suppressor cells (MDSCs) have the capacity to suppress T-cell–mediated immune responses and impact the clinical outcome of cancer, infections, and transplantation settings. Although MDSCs were initially described as bone m
Externí odkaz:
https://doaj.org/article/b15945dc1e8e473fb56edb73bec00b22
Autor:
Pieter D. de Veij Mestdagh, Eric van Werkhoven, Arash Navran, Jan Paul de Boer, Willem H. Schreuder, Wouter V. Vogel, Abrahim Al-Mamgani
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 17, Iss , Pp 7-13 (2019)
Background: The vast majority of patients with head and neck squamous cell carcinoma (HNSCC) routinely undergo elective nodal irradiation (ENI) to both sides of the neck. Little is known about the extent to which bilateral ENI prevents regional failu
Externí odkaz:
https://doaj.org/article/c1f09a52719641d29d5892c4d90879f0
Autor:
Maarten L. Donswijk, Marceline W. Piek, Zing Cheung, Maurits Wondergem, Marcel P. M. Stokkel, Jan Paul de Boer, Iris M. C. van der Ploeg
Publikováno v:
European Radiology. 33:3377-3385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30e6e0faefa8212a6a3e56485d17ff76
https://doi.org/10.1007/s00330-023-09492-5
https://doi.org/10.1007/s00330-023-09492-5
Autor:
Berbel L M, Ykema, Andrea, Gini, Lisanne S, Rigter, Manon C W, Spaander, Leon M G, Moons, Tanya M, Bisseling, Jan Paul, de Boer, Wieke H M, Verbeek, Pieternella J, Lugtenburg, Cecile P M, Janus, Eefke J, Petersen, Judith M, Roesink, Richard W M, van der Maazen, Berthe M P, Aleman, Gerrit A, Meijer, Flora E, van Leeuwen, Petur, Snaebjornsson, Beatriz, Carvalho, Monique E, van Leerdam, Iris, Lansdorp-Vogelaar
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention, 31, 12, pp. 2157-2168
Cancer Epidemiology, Biomarkers & Prevention, 31, 2157-2168
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31(12), 2157-2168. American Association for Cancer Research Inc.
Cancer Epidemiology, Biomarkers & Prevention, 31, 2157-2168
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 31(12), 2157-2168. American Association for Cancer Research Inc.
Background: Hodgkin lymphoma survivors treated with infradiaphragmatic radiotherapy (IRT) and/or procarbazine have an increased risk of developing colorectal cancer. We investigated the cost-effectiveness of colorectal cancer surveillance in Dutch Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fac7b7c10c302dcc4788c8daa9c7e21
http://www.scopus.com/inward/record.url?scp=85143379645&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85143379645&partnerID=8YFLogxK
Autor:
Reinout H. de Roest, Martijn van der Heijden, Frederik W.R. Wesseling, Emma J. de Ruiter, Martijn W. Heymans, Chris Terhaard, Marije R. Vergeer, Jan Buter, Lot A. Devriese, Jan Paul de Boer, Arash Navran, Ann Hoeben, Conchita Vens, Michiel van den Brekel, Ruud H. Brakenhoff, C. René Leemans, Frank Hoebers
Publikováno v:
de Roest, R H, van der Heijden, M, Wesseling, F W R, de Ruiter, E J, Heymans, M W, Terhaard, C, Vergeer, M R, Buter, J, Devriese, L A, de Boer, J P, Navran, A, Hoeben, A, Vens, C, van den Brekel, M, Brakenhoff, R H, Leemans, C R & Hoebers, F 2022, ' Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer ', Radiotherapy and Oncology, vol. 175, pp. 112-121 . https://doi.org/10.1016/j.radonc.2022.08.013
Radiotherapy and Oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and Oncology, 175, 112-121. Elsevier Ireland Ltd
Radiotherapy and oncology, 175, 112-121. Elsevier Ireland Ltd
BACKGROUND: Definitive concomitant cisplatin-based chemoradiotherapy (CRT) is the current gold standard for most patients with advanced stage head and neck squamous cell carcinoma (HNSCC) of the pharynx and larynx. Since previous meta-analysis on CRT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a081d2140a35c3df4f3a4a0fb43a4001
https://doi.org/10.1016/j.radonc.2022.08.013
https://doi.org/10.1016/j.radonc.2022.08.013